Mouth Neoplasms

Search with Google Search with Bing
Information
Disease name
Mouth Neoplasms
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00341497 Active, not recruiting Biomarkers for Oral Cancer August 28, 1996 October 4, 2024
NCT06231537 Completed N/A Visual Oral Examination for Early Detection of Oral Cancer in High-Risk Individuals December 1, 2023 January 10, 2024
NCT00721799 Completed Phase 2 F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients March 1, 2008 December 31, 2014
NCT00953849 Completed Phase 1/Phase 2 Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity November 2009 December 2015
NCT01104714 Completed Pharmacogenetic Response to Chemotherapy Induction for ORL Cancers April 2010 July 2014
NCT01195922 Completed Phase 1/Phase 2 Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma August 2010 December 2015
NCT01553851 Completed Phase 2 GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer February 2013 December 2015
NCT01649349 Completed Early Phase 1 The Feasibility Study of Dual-Section Nasogastric Tube May 2012 June 2012
NCT02604121 Completed N/A Cytological Screening for Early Diagnosis of Precancerous or Cancerous Lesions of Oral Cavity February 2013 February 2019
NCT04009811 Completed N/A A New Membrane Obturator Prothesis Concept for Soft Palate Defects July 17, 2020 July 15, 2022
NCT05774483 Not yet recruiting N/A Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative April 2023 April 2034
NCT05296941 Recruiting N/A Oral Cancer Screening for Early Detection of Premalignant Disorders (PMOD) August 1, 2023 December 31, 2029
NCT02290145 Recruiting Phase 2 Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage December 2016 December 2026
NCT02285530 Recruiting Phase 2 GDF15 Based TPF Induction Chemotherapy for OSCC Patients December 1, 2019 December 31, 2025
NCT02285543 Terminated Phase 2 A Phase II Trial of TPF Induction Chemotherapy in cN2 OSCC Patients December 1, 2016 July 30, 2023
NCT00272181 Terminated Phase 2 Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer January 2006 October 2007
NCT00412776 Terminated Phase 2/Phase 3 Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer December 2005 April 2008
NCT01216020 Terminated Phase 2 Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer October 2010 May 20, 2015
NCT00193843 Unknown status Phase 3 Oral Cancer Adjuvant Therapy (OCAT) Trial June 2005 June 2017
MeSH unique ID (MeSH (Medical Subject Headings))
D009062